Author:
Abro Asmat,Greenhall George H. B.,Nitsch Dorothea
Publisher
Springer International Publishing
Reference21 articles.
1. Hole B, Gilg J, Casula A, Methven S, Castledine C. UK renal registry 20th annual report: UK renal replacement therapy adult incidence in 2016. Nephron. 2018;139(suppl1):13–46.
2. MacNeill S, Ford D, Evans K, Medcalf. UK renal registry 20th annual report: UK renal replacement therapy adult prevalence in 2016. Nephron. 2018;139(suppl1):47–74.
3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for evaluation and management of chronic kidney disease. Kidney Int. 2013;3(Suppl):1–150.
4. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17–28.
5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(1):1–12.